Quadrant Capital Group’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$275K Sell
2,337
-619
-21% -$86.5K 0.01% 1164
2025
Q4
$484K Buy
2,956
+1,047
+55% +$164K 0.01% 930
2025
Q3
$255K Buy
+1,909
New +$232K 0.01% 1193
2025
Q2
Sell
-2,660
Closed -$338K 2320
2025
Q1
$338K Buy
2,660
+2,283
+606% +$351K 0.01% 1006
2024
Q4
$54.3K Sell
377
-104
-22% -$14.9K ﹤0.01% 1369
2024
Q3
$71.6K Buy
481
+91
+23% +$13K 0.01% 1264
2024
Q2
$49.2K Sell
390
-368
-49% -$57.7K ﹤0.01% 1407
2024
Q1
$139K Buy
758
+109
+17% +$20.8K 0.01% 825
2023
Q4
$117K Buy
649
+85
+15% +$13.2K 0.01% 903
2023
Q3
$89.7K Buy
564
+211
+60% +$34.5K 0.01% 940
2023
Q2
$49.9K Sell
353
-372
-51% -$59.6K 0.01% 1263
2023
Q1
$122K Buy
725
+132
+22% +$23.6K 0.01% 728
2022
Q4
$100K Sell
593
-126
-18% -$22.9K 0.01% 766
2022
Q3
$135K Buy
719
+346
+93% +$73K 0.02% 564
2022
Q2
$61K Buy
373
+175
+88% +$27.7K 0.01% 808
2022
Q1
$38K Sell
198
-2
-1% -$380 ﹤0.01% 1041
2021
Q4
$53K Sell
200
-19
-9% -$5.12K 0.01% 916
2021
Q3
$63K Buy
219
+62
+39% +$15.9K 0.01% 771
2021
Q2
$31K Sell
157
-37
-19% -$7.18K ﹤0.01% 1027
2021
Q1
$38K Buy
194
+41
+27% +$8.41K 0.01% 926
2020
Q4
$29K Buy
153
+6
+4% +$1.09K 0.01% 948
2020
Q3
$22K Sell
147
-56
-28% -$8.01K ﹤0.01% 921
2020
Q2
$25K Sell
203
-1,056
-84% -$124K 0.01% 975
2020
Q1
$121K Buy
1,259
+18
+1% +$1.74K 0.02% 517
2019
Q4
$113K Hold
1,241
0.01% 905
2019
Q3
$93K Hold
1,241
0.01% 914
2019
Q2
$105K Buy
1,241
+1,200
+2,927% +$81.8K 0.02% 841
2019
Q1
$2K Hold
41
﹤0.01% 2086
2018
Q4
$2K Hold
41
﹤0.01% 1931
2018
Q3
$2K Hold
41
﹤0.01% 1901
2018
Q2
$1K Hold
41
﹤0.01% 2055
2018
Q1
$1K Hold
41
﹤0.01% 2042
2017
Q4
$1K Hold
41
﹤0.01% 1990
2017
Q3
$1K Hold
41
﹤0.01% 2007
2017
Q2
$0 Hold
41
﹤0.01% 2016
2017
Q1
$1K Hold
41
﹤0.01% 1861
2016
Q4
$1K Hold
41
﹤0.01% 1772
2016
Q3
$1K Hold
41
﹤0.01% 1754
2016
Q2
$1K Hold
41
﹤0.01% 1733
2016
Q1
$1K Buy
+41
New +$1K ﹤0.01% 1572

Other funds holding RGEN

Quadrant Capital Group's RGEN Position: Q1 2026 in Review

Quadrant Capital Group reduced its Repligen (RGEN) stake by 21% in Q1 2026, selling an estimated $86.5K and leaving 2,337 shares worth $275K. The position accounts for 0.01% of the portfolio, ranked #1164.

Quadrant Capital Group first reported a position in RGEN in Q1 2016 and has held it in 40 quarters since. The position peaked at $484K in Q4 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Quadrant Capital Group held 2,337 shares of Repligen worth $275K as of Q1 2026.
  • Quadrant Capital Group sold 619 Repligen shares in Q1 2026, an estimated $86.5K.
  • Repligen made up 0.01% of Quadrant Capital Group's portfolio in Q1 2026, its #1164 holding.
  • Quadrant Capital Group first reported a position in Repligen in Q1 2016 and has held it in 40 quarters since.
  • Quadrant Capital Group's Repligen position peaked at $484K in Q4 2025.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.